AR057944A1 - Procedimiento para preparar compuestos de pirazolilo e imidazolilo biciclicos - Google Patents

Procedimiento para preparar compuestos de pirazolilo e imidazolilo biciclicos

Info

Publication number
AR057944A1
AR057944A1 ARP060105215A ARP060105215A AR057944A1 AR 057944 A1 AR057944 A1 AR 057944A1 AR P060105215 A ARP060105215 A AR P060105215A AR P060105215 A ARP060105215 A AR P060105215A AR 057944 A1 AR057944 A1 AR 057944A1
Authority
AR
Argentina
Prior art keywords
compound
alkyl
formula
chloro
phenyl
Prior art date
Application number
ARP060105215A
Other languages
English (en)
Spanish (es)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR057944A1 publication Critical patent/AR057944A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ARP060105215A 2005-11-28 2006-11-27 Procedimiento para preparar compuestos de pirazolilo e imidazolilo biciclicos AR057944A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74059005P 2005-11-28 2005-11-28

Publications (1)

Publication Number Publication Date
AR057944A1 true AR057944A1 (es) 2007-12-26

Family

ID=38067595

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060105215A AR057944A1 (es) 2005-11-28 2006-11-27 Procedimiento para preparar compuestos de pirazolilo e imidazolilo biciclicos

Country Status (4)

Country Link
JP (1) JP2007145842A (fr)
AR (1) AR057944A1 (fr)
TW (1) TW200804398A (fr)
WO (1) WO2007060525A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017140771A1 (fr) 2016-02-18 2017-08-24 Syngenta Participations Ag Dérivés de pyrazole à activité pesticide
WO2018185191A1 (fr) 2017-04-05 2018-10-11 Syngenta Participations Ag Dérivés de pyrazole actifs sur le plan pesticide
US20200288713A1 (en) 2017-08-11 2020-09-17 Syngenta Participations Ag Pesticidally active pyrazole derivatives
EP3665166A1 (fr) 2017-08-11 2020-06-17 Syngenta Participations AG Dérivés de pyrazole actifs sur le plan pesticide
AR112673A1 (es) 2017-08-11 2019-11-27 Syngenta Participations Ag Derivados de pirazol activos como plaguicidas
WO2020164994A1 (fr) 2019-02-13 2020-08-20 Syngenta Crop Protection Ag Dérivés de pyrazole à action pesticide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050010592A1 (en) 2003-07-08 2005-01-13 John Guthrie Method and system for taking a data snapshot
US7151097B2 (en) * 2003-11-07 2006-12-19 Pfizer Inc. Bicyclic pyrazolyl and imidazolyl compounds and uses thereof

Also Published As

Publication number Publication date
WO2007060525A3 (fr) 2007-10-04
JP2007145842A (ja) 2007-06-14
WO2007060525A2 (fr) 2007-05-31
TW200804398A (en) 2008-01-16

Similar Documents

Publication Publication Date Title
AR046831A1 (es) Compuestos de pirazolilo e imidazolilo biciclicos y usos de los mismos
AR057944A1 (es) Procedimiento para preparar compuestos de pirazolilo e imidazolilo biciclicos
ES2572148T3 (es) Un método para el tratamiento de la enfermedad de Pompe usando 1-desoxinojirimicina y derivados
AR054560A1 (es) Espiropiperidina como inhibidores de beta-secretasa para el tratamiento de la enfermedad de alzheimer
AR085960A1 (es) 1,3-oxazinas como inhibidores de la bace1 y/o de la bace2
AR061372A1 (es) Amino-imidazoles y sus usos como medicamentos para el tratamiento de mal de alzheimer, demencia y neurodegeneracion
NO20063446L (no) Tiazolderivater
AR061371A1 (es) Amino - imidazolonas y su uso como medicamento para la enfermedad de alzheimer y otras enfermedades neurodegenerativas.
HRP20151030T1 (hr) Kondenzirani derivat aminodihidrotiazina
AR079327A1 (es) Derivados de 2-amino-5,5-difluor -5,6-dihidro-4h-(1,3) oxazin-4-il) fenil)-amida
CO6260018A2 (es) Combinaciones de principios activos que contienen derivados de acido tetramico sustituidos con espirocetales
AR053203A1 (es) Pirazoles y sus derivados
AR082985A1 (es) INHIBIDORES DE PI3K-d Y METODOS DE SU USO Y PREPARACION
AR048413A1 (es) Compuestos prolina 3,4- (ciclopentil) - fusionados , como inhibidores de serina proteasa ns3 del virus de la hepatitis c
EP1982982A4 (fr) Nouveau derive de coumarine ayant une activite antitumorale
AR048241A1 (es) Compuestos azufrados como inhibidores de la serina proteasa ns3 del virus de la hepatitis c .
CO5640111A2 (es) Ligandos del receptor cannabinoide y usos de los mismos
AR047903A1 (es) Compuestos como inhibidores de serina proteasa ns3 del virus de la hepatitis c
NO20074620L (no) Spiroheterocykliske forbindelser og deres anvendelse som medikamenter
AR044036A1 (es) Compuestos de pirazolopirimidinas y pirazolopiridinas como ligandos de receptor cannabinoide, composiciones farmaceuticas y usos de los mismos
MX2009008781A (es) Derivados de ciclohexano espirociclicos.
NO20091858L (no) Hydrobenzamid derivater som inhibitorer av HSP90
EA201101588A1 (ru) Инсектицидные соединения
BR112014004235A2 (pt) derivados de isoxazolina como compostos inseticidas
AR050250A1 (es) Derivados de tetrahidroisoquinolilsulfonamidas, su preparacion y su utilizacion en terapeutica

Legal Events

Date Code Title Description
FB Suspension of granting procedure